Hussein Chalhoub

Suggest Changes
Learn More
High-level carbapenem resistance is worryingly increasing in clinical isolates and is often attributed to carbapenemase expression. This study aimed to determine the mechanisms leading to high-level(More)
In Pseudomonas aeruginosa collected from cystic fibrosis (CF) patients, we previously observed 24% of resistance to ceftazidime-avibactam in isolates negative for carbapenemases and ESBLs. Our aim(More)
  • 1